Search

In order to effectively utilize the photovoltaic properties of gallium arsenide, its surface/interface needs to be properly prepared. In the experiments described here we examined eight different paths of GaAs surface treatment (cleaning, etching, passivation) which resulted in different external quantum efficiency (EQE) values of the tested photovoltaic (PV) cells. Atomic force microscopy (AFM) and scanning electron microscopy (SEM) examinations were conducted to obtain structural details of the devices. X-ray photoelectron spectroscopy (XPS) with depth profiling was used to examine interface structure and changes in the elemental content and chemical bonds. The photoluminescence (PL) properties and bandgap measurements of the deposited layers were also reported. The highest EQE value was obtained for the samples initially etched with a citric acid-based etchant and, in the last preparation step, either passivated with ammonium sulfide aqueous solution or treated with ammonium hydroxide solution with no final passivation. Subsequent I–V measurements, however, confirmed that from these samples, only the sulfur-passivated ones provided the highest current density. The tested devices were fabricated by using the ALD method.

Hereby the possible applications of oxide nanoparticles in the cancer diagnostics and therapy are presented. Cancer diseases are nowadays one of the most common causes of death in the highly-developed countries. Discussed will be the current clinical cancer detection methods with their shortcomings. The role of nanomedicine in cancer medicine and the potential applications of nanoparticles debated in the literature will be critically evaluated. In the second part, the most common methods for the nanoparticle synthesis will be discussed. Finally, the system for cancer detection based on the enhanced permeation-retention of multimodal high-k oxide nanoparticles doped with lanthanides will be proposed for both for themagnetic resonance imaging (non-gadolinium contrast agents) and for fluorescence guided biopsy and surgery.

Two-step synthesis of Y2O3:Eu nanostructures was performed. It includes microwave driven hydrothermal and calcination stages. Performed route results in crystallization of Y4O(OH)9(NO3):Eu crystals initially, then Y2O3:Eu crystals after calcination. Arranged Eu contents in relation to overall cation quantity were set to 2 mol%, 10 mol% and 20 mol%. Varying europium concentrations influence habit of obtained Y4O(OH)9(NO3):Eu crystals from needle-like to plate-like and as a result, also shapes of final Y2O3:Eu nanostructures. Additionally, certain amount of Eu2+ ions was detected in as-grown material using laser spectroscopy and decay kinetics measurements. Obtained material was calcined at 1200 °C in the air, which results in oxidation of Eu2+ ions and crystallization of small number of cubic Eu2O3 nanocrystals. Characterization of obtained materials was performed using XRD, SEM, TEM, EDX, CL, Raman and photoluminescence spectroscopy.

Europium doped hafnium dioxide nanoparticles were crystallized using biologically friendly microwave hydrothermal method and employed in observation of small rodents tissues. Main solvent in synthesis is water, in consequence nanoparticles are found surrounded by thin hydroxide layer. Size of the nanoparticles is controlled by temperature of calcination. 1200 °C heating causes drop of luminescence intensity, explained as damage of high symmetry surface emission centers in the nanocrystals. On the other hand, growth of crystallites increases intensity of X-ray and electron beam excited luminescence. This makes them promising activator in photodynamic therapy.

In order to effectively utilize the photovoltaic properties of gallium arsenide, its surface/interface needs to be properly prepared. In the experiments described here we examined eight different paths of GaAs surface treatment (cleaning, etching, passivation) which resulted in different external quantum efficiency (EQE) values of the tested photovoltaic (PV) cells. Atomic force microscopy (AFM) and scanning electron microscopy (SEM) examinations were conducted to obtain structural details of the devices. X-ray photoelectron spectroscopy (XPS) with depth profiling was used to examine interface structure and changes in the elemental content and chemical bonds. The photoluminescence (PL) properties and bandgap measurements of the deposited layers were also reported. The highest EQE value was obtained for the samples initially etched with a citric acid-based etchant and, in the last preparation step, either passivated with ammonium sulfide aqueous solution or treated with ammonium hydroxide solution with no final passivation. Subsequent I–V measurements, however, confirmed that from these samples, only the sulfur-passivated ones provided the highest current density. The tested devices were fabricated by using the ALD method.

Zinc oxide nanoparticles were synthesized with microwave hydrothermal technique and tested as luminescent contrast for biological imaging. Luminescence was activated by Eu3+ ions embedded in the nanoparticle matrix in the increasing concentrations of 1, 5 and 10 %mol. It was found that europium did not create a separate crystalline phase up to the concentration as high as 5 %mol. However, Eu3+ ions did not substitute Zn2+ in the host lattice, but allocated in the low symmetry environment. It was proposed that europium was locating in the inter-grain space or on the surface of nanoparticles. The luminescence intensity in ZnO:Eu, as well as the size of particles, increased with the Eu ion concentration. Moreover, in 10 %mol Eu sample, the separate phase of Eu-hydroxide was identified with crystals of micrometre length. Interestingly, in vivo study revealed, that contrary to the in silico experiments, following gastric gavage, the brightest nanoparticle-related luminescence signal was observed at 1 %mol. concentration of Eu. Since the alimentary uptake of nanoparticles was related to their size, we concluded that the increase in luminescence at 5 and 10 %mol. Eu concentrations was associated with the largest ZnO:Eu and Eu-hydroxide particles that did not cross the gastrointestinal barrier.

Well-aligned ZnO nano/micro-rods with identical crystallographic orientation were synthesized on a c-plane GaN template, using a microwave-assisted hydrothermal method at 50 °C for duration of 2 min. The ZnO nanorods exhibited true epitaxial growth, in contrast to most of the previously reported methods, which involve nucleation on a ZnO buffer layer pre-deposited on the substrate. Homogeneous in-plane alignment as well as the c-axis orientation were confirmed by X-ray diffraction measurements and TEM analysis. More importantly, in the photoluminescence spectra of the nanorods a strong, narrow excitonic emission and an extremely weak deep level emission were observed, indicating high optical quality. The diameter was controlled by adjusting pH of the solution used in the growth process. The main achievement of the research was the opportunity to obtain oriented, high quality ZnO nano/microrods, using a surprisingly quick, cheap, and safe growth process, without the use of toxic substances or ultra-high purity compounds.

Perovskites, garnets, monoclinic forms, and lately also oxyhydroxides doped with rare-earth ions have been drawn large attention due to their beneficial optical and photovoltaic properties. In this work, we have shown that several forms of crystals from Y–Al–O family can be synthesized using microwave driven hydrothermal technique using different pH and post-growth annealing at different temperatures. The structural and optical properties of these crystals were investigated as a function of hydrothermal crystallization conditions. For this purpose, x-ray diffraction, scanning electron microscopy, energy-dispersive x-ray spectroscopy, transmission electron microscopy, photoluminescence, and photoluminescence excitation studies were performed. All the structures have been doped with Eu3+ ions which are known as a local symmetry sensor because various symmetries generate different crystal fields and thus affect their luminescence spectra. The optical properties of the obtained nanoparticles in correlation with their structure and chemical composition are discussed.

The use of nanoparticles in medicine is a rapidly growing research field with numerous potential applications, especially in the field of cancer diagnosis and therapy. Nanoparticles can be intrinsically diagnostic of therapeutic, or they can be conjugated with diagnostic or therapeutic compounds. Nanoparticles may also passively or actively target tumor cells specifically using the enhanced permeation and retention (EPR) effect, or the addition of targeting ligands to their surface. This may provide a diagnostic or/and therapeutic tools to target primary as well as metastatic tumors. The transport, distribution and toxicity of nanoparticles depends greatly on their size and composition, thus every new formulation needs to be extensively researched. This work was focused on the development of Tb-doped ZrO2 nanoparticles (NPs) for application in cancer imaging. Obtained nanoparticles were below 10 nm with very low influence of Tb concentration on size. Terbium stabilization of ZrO2 had influence on the luminescence properties of obtained material. Partially stabilized zirconium dioxide exhibited broad host related emission peaking at 500 nm, disappearing with the terbium content. We confirmed alimentary absorption and wide distribution of luminescent ZrO2:Tb nanoparticles in mice with their gradual accumulation in the experimentally induced mammary cancers. Furthermore, a high concentration of NPs was found within the lung metastases as opposed to healthy lung tissue, where no NPs-related signal was observed.

Recent decades have brought rapid development in the field of nanotechnology, which has led to applications of nanoparticles in many industries. Unique properties of nanoparticles and their biocompatibility increase their potential as drug carriers in drug-delivery systems. Prof. Marek Godlewski’s team from the Institute of Physics PAS has developed wide band-gap metal oxide nanoparticles doped with rare-earth metals for applications as fluorescent markers. The potential of those nanoparticles to cross the closed gut barrier after alimentary application has prompted their use in drug delivery systems. In this study, we show that after conjugation with a model bioactive substance, lectin (Phaseolus vulgaris), these nanoparticles retained their advantageous properties and, following oral administration (10 mg/ml in RO, 0.3 ml/mouse), entered a variety of organs in the mouse model. Internal organs collected at key time points were analysed under a scanning cytometer and a confocal microscope. The results show that the conjugation reduced, but did not completely abolish, the capacity of nanoparticles to penetrate physiological barriers (intestinal, blood-brain barrier) in the organism.

Iron is the crucial element for living organisms and its deficiency is described as the most common nutritional disorder all over the world. Nowadays, more effective and safe iron supplementation strategies for both humans and animals become one of the most important challenges in the therapy of nutritional deficiencies. Our previous in vivo studies confirmed safety and biodegradability of in-house manufactured zinc oxide-based nanoparticles and their rapid distribution to majority of organs and tissues in the body. In vitro examinations performed on Caco-2 cell line, a model of epithelial cells of the gastrointestinal tract, revealed a low toxicity of studied nanomaterials. In the current study, we investigated biodegradable zinc oxide nanoparticles doped with Fe(III) as a perspective supplementation strategy for iron deficiency. Biodegradable ZnO:Fe nanoparticles were intra-gastrically administered to adult mice and following 24 h, animals were sacrificed with collection of internal organs for further analyses. The iron concentration measured with atomic absorption spectrometry and histological staining (Perl’s method) showed a rapid distribution of iron-doped nanoparticles to tissues specifically related with iron homeostasis. Accumulation of iron was also visible within hepatocytes and around blood vessels within the spleen, which might indicate the transfer of Fe-doped nanoparticles from the bloodstream into the tissue. Reassuming, preliminary results obtained in the current study suggest that biodegradable ZnO nanoparticles doped with Fe might be a good carriers of exogenous iron in the living body. Therefore, subsequent investigations focus on determination an exact mechanisms related with an iron deposition in the tissue and influence of nanoparticle carriers on iron metabolism are required.

The Effect of Synthesis Pressure on Properties of Eu-Doped ZnO Nanopowders Prepared by Microwave Hydrothermal Method J. Rosowska, J. Kaszewskia,∗, B. Witkowski, Ł. Wachnicki and M. Godlewski Institute of Physics, Polish Academy of Sciences, Aleja Lotnikow 32/46, PL–02668 Warsaw, Poland Dept. of Mathematics and Natural Sciences College of Science, Cardinal S. Wyszynski University, Dewajtis 5, 01-815 Warsaw, Poland

Europium doped ZnO nanopowders made by microwave hydrothermal method are investigated. As zinc oxide precursor zinc nitrate(V) hexahydrate (Zn(NO3)2·6H2O) was used. Two types of nanopowder samples are examined: as grown and annealed at 750 °C in air atmosphere. We investigate the structural, morphological and optical prosperities of europium doped ZnO. Results of scanning electron microscopy, X-ray diffraction, photo- and cathodoluminescence investigations and also CIE1961 chromaticity diagram are presented.

Microwave hydrothermal growth of Y2O3 crystallites results in needle-shaped aggregates of μm length. Thermal treatment has little influence on the material microstructure, but significant impact on the nanometric level. Nanoparticles doped with europium show an intense red luminescence, related to the 5D0 → 7F2 transition of Eu3+ ions. The luminescence intensity increases with the calcination temperature and is accompanied by increasing size of Y2O3:Eu crystallites. EPR studies show the absence of Eu2+ related signals in the material. Y2O3:Eu nanoparticles crystallized via a microwave hydrothermal method were employed as luminescent biomarkers in mice. The initial tests confirmed their applicability as biological markers. Persorption of the Y2O3:Eu nanoparticles after IG in the adult mouse duodenum, brain and liver is reported.

Thermally induced crystallization of cubic Eu2O3 obtained with the microwave hydrothermal method has been investigated. The starting material crystallized in the form of needle-shaped agglomerates of nanocrystalline hexagonal Eu(OH)3. Thermal treatment up to 800 °C induced the crystallization of cubic Eu2O3, after further calcination at 1200 °C in the air a monoclinic phase appeared. The phase transformation caused abnormal reduction of Eu3+ ions, related to the oxygen vacancy creation during sintering of the oxide crystallites. The crystallization process of cubic Eu2O3 occurred within the agglomerates without change of their shapes. The cubic form exhibited bright emission of Eu3+ related luminescence with intensity increasing with the size of crystallites.

In this paper a new generation of non-toxic nanoparticles based on the zirconium oxide doped with 0.5%Tb and co-doped by the range of 0–70% with Y was evaluated for the use as a fluorescent biomarker of neuronal trafficking. The ZrO 2 :Tb nanoparticles were created by microwave driven hydrothermal method. Influence of the yttrium content and thermal processing on the Tb 3+ related luminescence emission was discussed. The higher intensities were achieved, when host was cubic and for the nanoparticles with 33 nm. Presence of yttrium was associated with the energy coupling of the host and dopant, wide excitation band is present at 309 and 322 nm before and after calcination respectively. For the experiment on living primary neurons, nanoparticles doped with 0.5%Tb and 7%Y were chosen based on their luminescence emission intensity. Recently transfer of the nanoparticles through the barriers in the organism including blood–brain barrier following their alimentary absorption was confirmed (Godlewski and Godlewski, 2012). This raised the possibility of the nanoparticle application as a tool in the neuroscience, and the question of potential mechanisms of nanoparticle turnover in neurons. Concentration of 0.001 mg/ml of ZrO 2 :0.5%Tb 7%Y in growth medium was added to the primary murine culture medium, and the intracellular trafficking of nanoparticles was observed following 15 min pre-incubation period. ZrO 2 :0.5%Tb 7%Y nanoparticles were dynamically absorbed by the neurons and the dynamic passage of transport vesicles containing ZrO 2 :0.5%Tb 7%Y nanoparticles was observed along the neuronal processes and in between two neighbouring neurons. Reassuming, the ZrO 2 :0.5%Tb 7%Y nanoparticles proved to be biocompatible and a valid tool to assess intracellular trafficking dynamics in the neurobiology.

Terbium doped yttrium oxide was prepared with the microwave hydrothermal method. The Y 2 O 3 :Tb nanomaterial crystallized as needle-like grains. Bright luminescence in the green region was observed. Significant luminescence intensity increase was obtained after thermal treatment. Reduction of terbium ions was observed after heating in the air atmosphere. Tb 4+ ions were found to be stabilized by crystal impurities. Hydroxyl species were found to have impact on vacancies elimination. The terbium ions were used as optical and magnetic indicator of the material properties.

Iron doped (in the range from 1 to 10 mol %) ZnO nanoparticles (NPs) were obtained by microwave hydrothermal method. The effects of iron content on morphology, crystal structure, optical and magnetic properties of ZnO nanoparticles were investigated by scanning electron microscopy (SEM), X-ray diffraction (XRD), energy-dispersive X-ray spectroscopy (EDX), cathodoluminescence (CL), photoluminescence (PL) and magnetic measurements. XRD studies revealed presence of ZnFe2O4 foreign phase in NPs for iron doping concentrations above 5% placing the solubility limit of Fe in ZnO NPs near this value. The photoluminescence and cathodoluminescence spectra show an increase of the intensity ratio between near band edge (NBE) and deep level emission band (DLE) of ZnO, which is tentatively related by us with intrinsic cracking of ZnO crystals. The blue-shift of NBE band maxima was observed as a concentration of Fe dopant increases. The results of magnetic measurements indicate superparamagnetic behavior of nanoparticles.

Nanotechnology as a new field of science is broadly exploited in a plethora of commercial uses. Biocompatible nanomaterials are also attractive for medical applications. However, an exact processes related with their biodistribution within the body needs to be examined. This study deals with future perspectives for biodegradable nanoparticle on the example of fluorescent ZnO NPs (zinc oxide nanoparticles), doped with europium (Eu) ions. The aim of the study was to evaluate distribution processes of biodegradable ZnO:Eu NPs within the living organism. ZnO:Eu NPs were administered intra-gastric (IG) (10 mg/ml, 0.3 ml/mouse) to adult Balb-c mice (n=35) and following 3h, 24h, 7d, 14d and 1m mice were sacrificed and internal organs were collected, as was described before [1]. For determination the excretion patterns of these nanostructure, ZnO NPs were orally administered to mice (n=24) with further measurement of zinc content in the feces of tested animals. All procedures were conducted according to local and EU regulations and approved by the LEC 44/2012. No pathological/behavioral changes were observed in mice. Biodegradable ZnO:Eu NPs revealed ability to overcome majority of physiological barriers in the organism, which renders them invaluable tool for biomedical applications. After 3h the presence of fluorescent NPs was already observed in key tissues and the peak of NPs distribution was observed at 24 h after IG in majority of tissues, including brain. Moreover, obtained results revealed fast and efficient clearance of ZnO NPs from the living organism, even following multiple administration of nanostructures (up to 4d after IG).

Magnetic Resonance Imaging (MRI) is considered a useful non-invasive method for cancer detection. However, MRI still has some limitations: low specificity for early-stage cancers as well as toxicity of Gadolinium ions, which were reported to accumulate in the nerve tissue and kidneys. Early cancer development and metastases monitoring are still difficult, because of the issues with permeability of contrasting agents through the blood-organ barriers. Nowadays, studies are being conducted to find the new contrasts with high magnetic moment, yet without gadolinium-induced toxicity. We propose an innovative, multimodal, high-k oxide-based contrasting nanoparticles (NPs), combining fluorescent properties of lanthanides with contrast in T1 and T2 spin relaxations. This material can facilitate both in-situ screening and visualization of tumour for fluorescence assisted biopsy or surgery. NPs used in our study were developed in the Institute of Physics, PAS. The NPs core was based on HfO2, doped with Eu ions, while Gd was used for positive control. Fluorescence was induced at 619nm, while emission was detectable at 630-650nm. The T1 and T2 relaxation times have been assessed using phantoms. Statistically significant changes were observed in T2 relaxation time. We used old rats, patients of the oncology clinic as an animal model. Prior to oral application of NPs (1mg/ml, 1ml/rat, LEC No 13/2015) the initial MRI screening of rats was performed. Weighted images T2 (3D FSE), SWI and SS-FSE were performed twice, 24 and 48 hours after IG. After imaging, tumours were surgically removed, for cytometric and pathomorphology evaluation.

In recent years nanotechnology gathered much attention due to promising applications in biomedicine. Using nanoparticles as drug carriers could allow for more effective and efficient therapy in treating cancer or neurological diseases. This is due to their unique properties such as enhancement of drug bioavailability or the ability to protect the drug from degradation. In this study we performed in vivo (BALB-c mice) and in vitro (Caco-2 cell line) experiments with Y2O3:Tb_lectin conjugates as well as pure lectin to characterize the dynamics of nanoparticles mediated drug uptake from gastro-intestinal tract. Mice were given 0.3ml of Y2O3:Tb_lectin conjugates or pure lectin suspension and were sacrificed after 3h, 24h and 1 week (Y2O3:Tb_lectin conjugates) or 3h and 24h (pure lectin). Cell cultures were incubated for 24h with increasing concentration (0.001mg/ml; 0.01mg/ml; 0.1mg/ml; 1mg/ml) of Y2O3:Tb_lectin or pure lectin. After analysing gathered data we concluded that our nanoparticles successfully conjugated with lectin and allowed for its transport through physiological barriers. NPs_Lectin conjugates undergo absorption, distribution and redistribution similarly as free nanoparticles do, although it decreased the efficiency of absorption compared to free nanoparticles. Lastly after reaching the tissue conjugates dissolved leading to lectin deposition in the tissue.

Thin films of wide band-gap oxides grown by Atomic Layer Deposition (ALD) are suitable for a range of applications. Some of these applications will be presented. First of all, ALD-grown high-k HfO2 is used as a gate oxide in the electronic devices. Moreover, ALD-grown oxides can be used in memory devices, in transparent transistors, or as elements of solar cells. Regarding photovoltaics (PV), ALD-grown thin films of Al2O3 are already used as anti-reflection layers. In addition, thin films of ZnO are tested as replacement of ITO in PV devices. New applications in organic photovoltaics, electronics and optoelectronics are also demonstrated Considering new applications, the same layers, as used in electronics, can also find applications in biology, medicine and in a food industry. This is because layers of high-k oxides show antibacterial activity, as discussed in this work.

Oxide nanoparticles doped with rare-earth ions are tested for applications as nanomarkers in biology and medicine, e.g. for early cancer diagnostics. In this work we describe properties of such markers obtained by a microwave hydrothermal technology. Nanomarkers based on oxide materials (ZnO) are grown and tested for medical and biological applications.

Zinc-based nanoparticles are promising materials for various applications, including in biomedicine. The aim of our study was to determine the effect of fluorescent europium-doped zinc oxide nanoparticles (ZnO:Eu NPs) on sperm parameters, cell apoptosis and integrity of the blood-testis barrier (BTB) in mice. Nanostructures were orally administered to adult mice (n = 34). Animals were sacrificed after 3 h, 24 h, 7 d and 14 d following oral administration. Sperm was collected and analysed for viability and kinetic parameters. Collected testes were quantitatively analysed for accumulation of ZnO:Eu NPs. Microscopic evaluation based on immunofluorescence and histopathological studies were also conducted. Results showed that ZnO:Eu NPs were able to overcome the BTB with their subsequent accumulation in the testis. No toxic or pro-apoptotic effects of nanoparticles on the male reproductive system were observed. The results suggested that ZnO:Eu NPs were able to accumulate in the testis with no negative impact on sperm parameters, tissue architecture or the integrity of the BTB.

Oxide nanoparticles (NPs) doped with rare-earth ions are tested for applications as nanomarkers in biology. The aim of this study was to investigate the intra-organism distribution of ZnO nanoparticles doped with europium following gastric gavage (IG) in mice. The study is an example of the innovative and comprehensive methodology in research on biodistribution of nanomaterials in the body. We used quantitative (AAS) and imaging (scanning cytometry, confocal microscope) methods of assessing the distribution of rare-earth doped ZnO nanoparticles in the living organism. Visualization of these processes in the body was possible because of high fluorescence yield of europium. Imaging methods applied in this study (scanning cytometry and confocal microscopy) seem to be crucial for understanding the uptake and distribution patterns of nanoparticles within the living organism.

Biodegradable zinc oxide nanoparticles (ZnO NPs) are considered promising materials for future biomedical applications. To fulfil this potential, biodistribution and elimination patterns of ZnO NPs in the living organism need to be resolved. In order to investigate gastrointestinal absorption of ZnO NPs and their intra-organism distribution, water suspension of ZnO or fluorescent ZnO:Eu (Europium-doped zinc oxide) NPs (10 mg/ml; 0.3 ml/mouse) was alimentary-administered (IG: intra-gastric) to adult mice. Internal organs collected at key time-points after IG were evaluated by AAS for Zn concentration and analysed by cytometric techniques. We found that Zn-based NPs were readily absorbed and distributed (3 h post IG) in the nanoparticle form throughout the organism. Results suggest, that liver and kidneys were key organs responsible for NPs elimination, while accumulation was observed in the spleen and adipose tissues. We also showed that ZnO/ZnO:Eu NPs were able to cross majority of biological barriers in the organism (including blood–brain-barrier).

Badania wspierane byly przez Unie Europejską w ramach Europejskiego Funduszu Rozwoju Regionalnego, w ramach dotacji Innowacyjna Gospodarka (POIG.01.01.02-00-008/08) oraz Narodowe Centrum Nauki poprzez granty (DEC-2012/07/N/ST3/03144 i DEC-2012/06/A/ST7/00398).

Fine particles of Fe 2 O 3 /ZnO were synthesized by wet chemical method. The morphological and structural properties of the mixed system were investigated by scanning electron microscopy, X-ray diffraction and X-ray photoelectron spectroscopy. The major phase was determined to be the cubic spinel phase of γ-Fe 2 O 3 maghemite with mean crystalline size of about 20 nm together with small amounts of hexagonal ZnO and ZnFe 2 O 4 . The magnetic properties of the material were investigated by ferromagnetic resonance (FMR) in the temperature range from liquid helium to room temperature. An asymmetric and very intense FMR signal was recorded exhibiting strong shift to low magnetic fields with decrease in temperature. Analysis of the FMR spectra in terms of two separate line components indicates the presence of strongly anisotropic interactions.

The paper deals with preparation of nanocrystalline zinc oxide doped with iron oxide obtained via calcination process. A mixture of iron and zinc hydroxides of various compositions was used as precursors of nanopowders. The samples were prepared by wet chemistry method – precipitation from the corresponding metals' nitrates' solutions using ammonia. The obtained hydroxides were filtered, dried and calcined at 573 K for 1 hour. A series of samples containing 5 to 95 wt.% of Fe2O3 was obtained. The phase composition of the samples was determined using XRD. Depending on the chemical composition the phases of hexagonal ZnO, and/or romboedric Fe2O3 and/or cubic ZnFe2O4 were identified. The mean crystallite size of ZnFe2O4 phase present in all the samples, determined using Scherrer's formula, varied from 8 to 12 nm. The morphology of the samples was investigated using SEM and HRTEM. X-ray photoelectron spectra of all the samples were analysed. A detailed spectroscopic and morphological analysis of the samples suggests a core-shell structure of the produced grains. (© 2010 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim)

First generation of biomarkers (fluorescence labels) is based on organic dyes. To replace them nanoparticles (NPs)/quantum dots (QDs) of highly fluorescent CdTe-, CdS- and CdSe-based biomarkers were introduced. Despite the fact that these NPs show some advantageous properties, their use is limited by blinking, spectral diffusion of emission and use of cadmium, which should be avoided in the case of biological and medical applications. This fact motivated us to develop new generation of biomarkers using biocompatible oxides - ZnO, ZnAl 2 O 4 and ZrO 2 . Their emission is activated by doping with rare earth (RE) ions.

This paper reports the observation of Tb(3+) 4f-4f emission gain in ZrO2 nanocrystals stabilized by Y2O3 as the amount of stabilizer increases from 0% to 10% mol. The nanocrystals were obtained via microwave solvothermal technology. The photoluminescence properties of as-grown samples are investigated. The possibility of biological applications of the material is tested on living organisms (mice). The result indicates the potential use of the studied material as a luminescent nanomarker.

A new inexpensive method of the ultra-fast growth of ZnO nanorods from the aqueous solution is described. This environment friendly and fully reproducible method allows growth of nanorods in about 1–3 min time on various substrates, without any catalyst or complexing agent. The substrates need to be coated with a layer of gold droplets, which nucleate the growth. Growth temperature does not exceed 50oC and growth can be performed at atmospheric pressure. Deionised water and zinc acetate are used as oxygen and zinc precursors, respectively. The method is characterised by simplicity and allows regulating size of the ZnO nanorods in a large extent. Due to simplicity and safety of this method, it is suitable for industrial applications, i.e., in the construction of gas sensors or highly sensitive light detectors (changes of sample resistivity upon illumination).